Mary Van Doren
Mary Van Doren, Executive Editorial Director at Dark Intelligence Group partner Mequoda Group, serves as DIG’s online editor. She optimizes DIG content for the Internet to ensure that it reaches the widest possible audience.
Mary’s experience includes writing search-optimized marketing copy both for Mequoda and for Mequoda clients, including the The Dark Intelligence Group, and directly tutoring clients in SEO content marketing. She has more than three decades of experience in both marketing and journalism. Just prior to joining Mequoda Group in 2012, she spent five years as Chief Copywriter for Elsevier Business Intelligence, where she helped promote publications, databases and conferences for C-suite executives in biopharma, medical devices and diagnostics.
Articles by Mary Van Doren
Doctors’ resistance to BeaconLBS comes to Florida legislature
From the Volume XXIII, No. 1 – January 19, 2016 Issue
CEO SUMMARY: THE DARK REPORT IS THE ONLY LAB INDUSTRY NEWS SOURCE to report on this important development. A hearing took place recently on a healthcare bill in the Florida senate. Physicians in Florida are working to get language inserted into a state law that would restrict the …
Lab Stakeholders Take Action to Prevent Drastic Cuts in the Medicare Lab Fee Schedule
From the Volume XXII, Number 18 – December 28, 2015 Issue
WITH MANY CLINICAL LABORATORY STAKEHOLDERS anticipating major revenue shortfalls due to the Protecting Access to Medicare Act lab test mar…
Official Makes Case in Favor of FDA LDT Guidance
From the Volume XXII, Number 18 – December 28, 2015 Issue
IN THIS EXCLUSIVE NEWS COVERAGE of a public appearance by a key FDA official, THE DARK REPORT provides lab executives and pathologists with a more nuanced understanding about the thinking behind the proposed …
Cleveland Clinic and related lab sue True Health Diagnostics
From the Volume XXII, Number 17 – December 7, 2015 Issue
THE DARK REPORT is the only lab industry news source to recognize the significance of the lawsuit between the Cleveland Clinic Foundation and Cleveland HeartLab against a new lab company, True Health Diagnostics. It is the latest chapter in a string…
Might Lawsuits Come Next in the Theranos Story?
From the Volume XXII, Number 16 – November 16, 2015 Issue
Tailored to the needs and interests of lab administrators and pathologists, THE DARK REPORT provides new insights into the continuing saga of Theranos. A stream of headline stories in recent weeks has painted the controversial lab testing company in an uncomplimentary way, and TDR p…
Lab Professionals Long Knew of Challenges at Theranos
From the Volume XXII No. 15 – October 26, 2015 Issue
CEO SUMMARY: As THE DARK REPORT has continually reported, pathologists and medical laboratory professionals in the San Francisco and Phoenix markets were aware for most of the past year that Theranos was not delivering to patients and consumers the specific lab testing services it regula…
Protecting Access to Medicare Act of 2014: Will price reporting rule drive small labs out of business?
From the Volume XXII No. 14 – October 5, 2015 Issue
This first assessment of the PAMA (Protecting Access to Medicare Act of 2014) proposed rule on market reporting of lab prices gives pathologists and lab executives insights about the good, the bad, and the…
New Developments in $1 Billion Laboratory Fraud Case
From the Volume XXII NO. 13 – September 14, 2015 Issue
IT’S THE $1 BILLION LABORATORY FRAUD that no one realized had grown so big. In this special issue of THE DARK REPORT, you’ll read how the next chapter of the federal whistleblower lawsuit against three specialty cardiology labs and certain individuals has pulled the curtain open on what …
Is New Cycle of Laboratory Fraud Plaguing the Industry?
From the Volume XXII No. 12 – August 24, 2015 Issue
CEO SUMMARY: Taken collectively, the growing number of federal investigations of lab companies and health insurer lawsuits against lab companies alleging fraudulent busine…
New company ready to heat up slow digital pathology market
From the Volume XXII No. 11 – August 3, 2015 Issue
IN THE 2000S, DIGITAL PATHOLOGY WAS THE HOT NEW TECHNOLOGY that held great potential to transform anatomic pathology in myriad ways, not the least of which was an essential tool to streamline pathologist workflow while suppor…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized